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Abstract: The aim of the study was to explore whether G-Protein-Coupled Receptor 30 (GPR30) was expressed
in rat testicular Sertoli cells and to assess the impact of monobutyl phthalate (MBP) on the expression of GPR30
in Sertoli cells. By using RT-PCR, Western-Blot and immunofluorescent microscopy, the expression of GPR30
in rat Sertoli cells was found at both gene and protein level. Cultures of Sertoli cells were exposed to MBP (10–
–1000 mM) or a vehicle. The results indicated that the expression of GPR30 increased at gene and protein levels
in Sertoli cells following administration of MBP even at a relatively low concentration. We suggest that changes
of GPR30 expression may play an important role in the effects of the xenoestrogen MBP on Sertoli cell function.
(Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 1, 18–24)
Key words: monobutyl phthalate, GPR30, Sertoli cell, xenoestrogen, nongenomic action, rat
Introduction
Phthalates belong to chemicals widely used in indus-
try. They include endocrine disrupting chemicals
(EDCs) acting as hormone-like agents that may in-
terfere with the synthesis, secretion, transport and
elimination of natural hormones in the body [1]. Di(n-
butyl) phthalate (DBP) is a weak estrogenic com-
pound extensively applied in the cosmetics industry
and medical products [2]. Data suggested that xe-
noestrogens, such as DBP, exert adverse effects on
the development of male reproductive system. For
example, DBP treatment in pregnant rats could cause
a set of disorders in male offspring, including Leydig
cell aggregation and hyperplasia, the suppression of
intratesticular testosterone level, an increased num-
ber of gonocytes, and the presence of multinucleated
gonocytes in fetal testis [3–5]. In addition, DBP ex-
posure in utero led to hypospadias, cryptorchidism,
prostate, epididymis and vas deferent agenesis, de-
creased anogenital distance and delayed preputial
separation [6] which resemble the symptoms of tes-
ticular dysgenesis syndrome related to diminished
testosterone action in the fetal period of life [7].
It was shown in previous studies that the majority
of xenoestrogens exerted their estrogenic effects pri-
marily by binding to classical estrogen receptors
(ERs). However, it has been demonstrated that all
the xenoestrogens possess a very weak affinity for ERs
[8]. For example, DBP is approximately six to seven
orders of magnitude less potent than 17b-estradiol
[2]. The mechanisms by which xenoestrogens might
affect the male reproductive system at a relatively low
concentration remain unknown. Besides the classical
genomic action, increasing evidence indicates that
estrogen can also cause rapid, nongenomic action by
binding to a specific membrane estrogen receptor [8].
The G-protein-coupled non-classical membrane ER
(GPCR), also known as GPR30, has been widely rec-
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ognized as a membrane ER which plays an impor-
tant role in nongenomic actions. It was demonstrat-
ed by many authors that binding of estrogen to GPR30
could trigger the up-regulation of intracellular Ca2+
and cAMP, and then activate the mitogen activated
protein kinase (MAPK) pathway [9]. Based on similar
chemical structure, xenoestrogens may also mimic such
nongenomic actions of estrogens.
Monobutyl phthalate (MBP), the active monoester
metabolite of DBP hydrolyzed by intestinal hydro-
lases upon ingestion and absorption in the gut [10,
11], could inhibit fetal testosterone synthesis, result-
ing in the anti-androgenic effect of DBP [12]. Addi-
tionally, MBP inhibited testicular descent in prenatal
rats after administering to pregnant rats from 15th to
17th gestational day [13]. In bovine adrenal chroma-
ffin cells and human neuroblastoma SH-SY5Y cells,
DBP and MBP suppressed the increase of the epiba-
tidine-induced Ca2+ concentration [14]. MBP was re-
ported to have estrogenic activity in several kinds of
animals and cell types, however its mechanism of ac-
tion needs to be determined.
Sertoli cells (SCs), located within the seminifer-
ous epithelium, are involved in the formation of blood-
testis barrier. SCs exert an important function in nour-
ishing and supporting germ cells and play an essen-
tial role in normal onset of spermatogenesis. It was
reported that exposure to MBP can destroy junction-
al structures between Sertoli cells [15], and it has been
suggested that specific impairment of Sertoli cell mi-
croenvironment can induce a dysfunction in sperm
production.
The aim of our study was to investigate whether
GPR30 is expressed in Sertoli cells and examine the
possible effect of MBP on the expression of GPR30
in Sertoli cells in rat testis. In the current study we
have demonstrated that GPR30 participated in the
response of MBP-treated Sertoli cells.
Material and methods
Primary culture of rat testicular Sertoli cells. Sprague-Daw-
ley rats were purchased from Nanjing Medical University
and kept in accordance with the NIH Guide for the Care
and Use of Laboratory Animals. Sertoli cells were isolated
from the testes of 28-day-old rats in accordance with the
method of Li with some modifications [16]. Testes were re-
moved and decapsulated, then washed twice in phosphate-
buffered saline (PBS). The seminiferous tubules were dis-
persed gently using ophthalmic forceps and then transferred
into 50 mL plastic tubes. The seminiferous tubules were di-
gested in 0.25% trypsin solution in a rocking incubator (35°C,
50 rpm, 7 min) to remove Leydig cells and other interstitial
tissue, followed by 0.1% collagenase I treatment (35°C, 200
rpm, 25 min) to remove the peritubular cells. The homoge-
nate was filtered through a 100-mesh (100 sieve meshes per
square inch) stainless steel filter, and collected by centrifu-
gation at 1200 rpm for 7 min. Cells were washed three times
in PBS. Isolated cells were placed on cell culture dishes at
a density of 1.5×106 cells/ml. Cells were grown initially in
DMED/F-12 medium with 5% fetal bovine serum (FBS), con-
taining sodium bicarbonate (2.4 mg/L), HEPES (15 mM/L),
penicillin (100 IU/mL), and streptomycin (100 IU/mL). Cells
were incubated in a humidified atmosphere of 95% air,
5%CO2 at 35°C. After 2 days of culture, Sertoli cells with
tiny protruding dendrites were attached to the bottom of
the dishes, while most of germ cells were suspended in the
medium. After the medium was changed the purity of the
cultured Sertoli cells was more than 95%.
Reverse Transcription-PCR assay. RT-PCR assay was used
to demonstrate the mRNA expression of GRP30 in Sertoli
cells. By using Column Animal RNAout kit (TIANDZ,
Beijing, China), total RNA was extracted from cultured Ser-
toli cells in vitro according to the manufacturer’s protocol.
Purity of the total RNA was determined by the ratio of ab-
sorbance readings at 260 nm and 280 nm, the result of 260/
/280 nm fell in the range of 1.8-2.0. After diluting the sam-
ples to obtain the same concentration (0.05 mg/mL), the to-
tal RNA was reverse-transcribed using the EasyScript First-
Strand cDNA Synthesis SuperMix (TranGen Biotech Co.,
Beijing, China). The resulting cDNA was used for PCR.
The PCR master mix contained 12.5 µL 2×Taq master mix
(BOERDI, Nanjing, China), 1 µL cDNA, 1 mL forward prim-
er (10 µM), 1 mL reverse primer (10 µM) and 9.5 mL nuclease-
free water. Primers specific for our target genes were de-
signed as showed in Table 1. 18S rRNA was chosen as
a housekeeping gene. Compared with beta-actin and glyc-
eraldehyde-3-phosphate dehydrogenase, 18S rRNA was the
most stable housekeeping gene and superior for normaliza-
tion in comparative analyses [17]. Reactions were run in
the following conditions: 1×95°C 2min, 27× [95°C 30s, 56°C
30s and 72°C 30s]. PCR products were separated on a 1%
agarose gel, stained with ethidium bromide and viewed un-
der a UV transilluminator (Junyi-Dongfang Co., Beijing,
China)
RT-PCR was also used to observe whether MBP expo-
sure in vitro alters the expression of GPR30 in Sertoli cells.
Purified Sertoli cells were plated into 6-well culture plates
at 1.5×105 cells/mL in 2 mL culture medium. After 24h in-
cubation cells were treated with 17b-estradiol (E2) (0.1 nM)
as positive control and MBP (0, 10, 100, 1000 mM), and in-
cubated at 35°C for 5, 10, 15, 30 min and 24 hours. GPR30
expression in the treated Sertoli cells was measured by
RT-PCR assay performed as described above.
Western blotting. Cells were washed twice with cold PBS
and lysed in a lysis buffer (50 mMTris–HCl pH 7.4, 150 mM
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NaCl, 1 mM PMSF, 1 mM EDTA, 1% Triton X-100 and 0.1%
SDS) for 30 min on ice. The lysate was centrifuged at 12,000×g
for 15 min, the supernatants were collected and protein con-
centration was determined by Bradford protein assay. Proteins
were separated by 12% SDS–polyacrylamide gel electrophore-
sis and electroblotted onto polyvinylidene fluoride (PVDF)
membrane (Roche, Mannheim, Germany) by standard pro-
cedures. Transferred blots were incubated sequentially with
blocking agent (5% non-fat milk in PBS-tween), primary anti-
GPR30 antibodies (Abcam Co., Hong Kong, China) and per-
oxidase conjugated secondary antibodies (Boster Company,
Wuhan, China). Signal detection was performed with an en-
hanced chemiluminescence detection kit. Band density was
measured by Bio-Rad Quantity One software.
Immunofluorescence study. Sertoli cells cultured on polyl-
ysine-coated coverslips for 24 h were fixed in 4% (wt/vol)
paraformaldehyde for 20 min and then permeabilized for
5 min with 0.25% (vol/vol) Triton X-100 at room tempera-
ture. After rinsing with PBS three times, cells were blocked
with 3% bovine serum albumin for 30 min. After washing,
cells were incubated with primary anti-GPR30 antibodies
(1:50 dilution) overnight at 4°C. Alexa Fluor 594 donkey
anti mouse IgG (Invitrogen, USA) was applied for 30 min
at 37°C to visualize staining. After three times washing, cells
were incubated with 1 µg/mL 4',6-diamidino-2-phenylindole
(DAPI, Invitrogen, USA) for 5 min to stain cell nuclei. The
coverslips were attached to glass slides using 90% glycerin
and visualized under a confocal scanning laser microscope.
Immunofluorescence was used to evaluate whether MBP
exposure in vitro alters the expression or location of GPR30 in
Sertoli cells. Sertoli cells were cultured on polylysine-coated
coverslips for 24 h. Cells were treated with MBP (0, 10, 100,
1000 mM) and incubated at 35°C for 5, 15, 30 and 60 min. After
incubation, immunofluorescence was used to detect the distri-
bution of GPR30 according to the protocol described above.
Results
The expression of GPR30 in Sertoli cells
The expression of GPR30 in Sertoli cells was demon-
strated at mRNA level (Figure 1), and at protein lev-
el by immunoblotting and cell immunofluorescence
analysis. Affinity-purified GPR30 antibody detected
a single band with an apparent molecular weight of
55 kDa in the immunoblot analysis (Figure 2). As
shown in Figure 3, GPR30 was mainly distributed on
cell membrane and not in cell nuclei.
Table 1. Primers used in RT-PCR experiment
GENE Primer information
Primer Sequence (5’–3’) Length
GPR30 Forward GGACGAGCAGTATTACGATA 460bp
Reverse CCAGCAGATGAAGAAGACA








Figure 1. GPR30 mRNA expression in Sertoli cells as
determined by RT-PCR. Figure shows only gel electropho-
resis of the PCR products and their respective molecular
weights (EtBr staining)
Figure 2. GPR30 protein expression in Sertoli cells as
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The effect of MBP on the expression
of GPR30 in Sertoli cells
Sertoli cells were treated with 17b-estradiol (E2) and
MBP at different concentrations and collected at dif-
ferent time points (5, 10, 15, 30 min and 24 h). The
results are presented in Figures 4 and 5. In the posi-
tive control group (E2 group), the level of GPR30
mRNA was gradually up-regulated from 5 to 15 min.
At low (10 mM) and high (1000 mM) concentrations
of MBP, there was a similar trend in GPR30 mRNA
expression with E2 group. However, after exposure
to MBP for 24 h, the data showed a downward trend
in the mRNA level of GPR30 (Figure 5). Protein dis-
tribution of GPR30 was mostly unchanged after ex-
posure to MBP for 30 and 60 min (Figure 6).
Discussion
In many animal and cell models it was shown that
environmental estrogens could induce rapid, cell-sur-
Figure 3. The distribution of GPR30 in untreated Sertoli cells. A: Nuclei of Sertoli cells were visualized by DAPI staining;
B: GPR30 protein presence in Sertoli cells was detected by Alexa Fluor 594 immunofluorescence; C: merged image
Figure 4. Effects of MBP on gene expression of GPR30 in Sertoli cells. Cells were treated with MBP at various concentra-
tions for 5, 10, 15 and 30 min. C: control group; E2: 17b-estradiol group; M1: 10 mM MBP; M2: 100 mM MBP; M3: 1000 mM
MBP. The experiments were repeated three times
Figure 5. Effects of MBP on gene expression of GPR30 in
Sertoli cells treated with MBP at various concentrations for
24 h. C: control group; E2: 17b-estradiol group; M1: 10 mM
MBP; M2: 100 mM MBP; M3: 1000 mM MBP. The experi-




C E2 M1 M2 M3 C E2 M1 M2 M3
C E2 M1 M2 M3 C E2 M1 M2 M3
10 min





C E2 M1 M2 M3
22 Y. Hu et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2013
10.5603/FHC.2013.003
www.fhc.viamedica.pl
face initiated nongenomic action [18, 19]. However,
there were few studies concerning whether GPR30
can be expressed in Sertoli cells and whether xe-
noestrogens can affect the expression of GPR30. The
results of the present study provide the first clear ev-
idence that estrogen membrane receptor GPR30 is
expressed in Sertoli cells in rat testes. The treatment
of Sertoli cells with MBP could up-regulate mRNA
expression level of GPR30 after short exposure, how-
ever, the level was down-regulated after cell exposure
to MBP for 24 hours. These results illustrate that
GPR30 may be regarded as a sensitive biochemical
marker for observing the rapid response of Sertoli
cells to MBP.
In the present in vitro study, we focused on the ef-
fect of relatively low concentrations of MBP on GPR30
expression. The selected doses of MBP could not in-
duce cytotoxicity to Sertoli cells. Our previous investi-
gations had shown that EC50 of MBP for inhibiting the
viability of Sertoli cells was 16mM [16], suggesting that
the doses used in our study did not affect cell viability.
It needs to be emphasized that the concentrations at
a micro-molar level used in our study are rarely en-
countered in the environment, which, however, does
not exclude toxicological implications of the current
study. MBP is present in a variety of foods and can be
accumulated to a high level in human body through
food intake, while it is not easily degraded [20].
Figure 6. Effects of MBP on changes in the expression of GPR30 in Sertoli cells. Cells were exposed to MBP at various
concentrations for 5, 15, 30 and 60 min. The expression of GPR30 was detected by immunofluorescence. C: control group;
E2: 17b-estradiol group; M1: 10 mM MBP; M2: 100 mM MBP; M3: 1000 mM
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In our study, we speculate that GPR30 is the bind-
ing site in the plasma membrane for MBP. As a mem-
ber of the rhodopsin-like family of G-protein-coupled
receptors spanning the membrane seven times,
GPR30 is an integral membrane protein that localiz-
es to the endoplasmic reticulum and plasma mem-
brane. GPR30 has a high affinity to estrogens, and
their binding results in intracellular calcium mobili-
zation and synthesis of phosphatidylinositol (3,4,5)-
-trisphosphatein the nucleus. This protein therefore
plays a role in the rapid nongenomic signaling events
widely observed following stimulation of cells and tis-
sues with estrogen-like chemicals [21, 22]. It is inter-
esting that a wide variety of xenoestrogens with di-
verse structures have strong binding affinities for
GPR30. For example, Bisphenol A has the binding
affinity to GPR30 as much as 8–50 times higher than
that to ERs. Nonylphenol and Kepone have the bind-
ing affinity for GPR30 3–4-fold higher than that for
the ERs. In contrast, the binding affinity of mycotox-
in for ERa is 8–20-fold higher than its affinity for
GPR30 [23–25]. The above data imply that GPR30
might mediate estrogen actions induced by xenoestro-
gens [9]. Treatment of GPR30-positive cells with es-
trogens could activate the intracellular signaling path-
ways. 17b-estradiol has been shown to activate Erk-
1/2 kinase via transactivation of the epidermal growth
factor (EGF) receptor by the release of proHB-EGF
from the cell surface [26].
In addition, xenoestrogens can activate the sec-
ond messenger system by binding to GPR30 [27].
Downstream of G-protein, estrogen-like chemicals
lead to activation of a SRC-like tyrosine kinase, phos-
phorylation of the adaptor protein SHC, and through
the activation of a metalloprotease, the extracellular
release of heparin-bound epidermal growth factor
(HB-EGF) [9].The release of HB-EGF activates the
EGF receptor resulting in the induction of the mito-
gen-activated protein kinase (MAPK) pathway. There
can be also other pathways involved. Phosphoinositi-
de 3-kinase (PI3K) pathway also could be activated
via GPR30. As a result of the accumulation of phos-
phatidylinositol 3,4,5-trisphosphate (PIP3), the anti-
apoptotic and proliferative kinase AKT becomes ac-
tivated [28, 29]. All of these signaling events happen
within seconds and minutes, furthermore, these sig-
nals elicit changes in the gene expression of a whole
network of transcription factors including SRF,
CREB, and members of the ETS family which pro-
motes the expression of a second wave of transcrip-
tion factors such as FOS, JUN, EGR1, ATF3,
C/EBPd, and NR4A2. Cells become literally repro-
grammed under the effect of this network of tran-
scription factors [30].
Our results indicate that MBP stimulates the gene
expression of GPR30 within 5–30 min, which corre-
sponds to the effects of 17b-estradiol. We speculate
that MBP caused a rapid, nongenomic effect through
binding with GPR30 in the cell membrane, then con-
verted into specific signaling pathway downstream and
mediated the mRNA expression of GPR30. We sug-
gest that after 24 hours GPR30 protein formed nega-
tive feedback to inhibit the mRNA level of GPR30 as
the dose of MBP rose. The present results showed
that MBP potentially interfered with the estrogen
action through GPR30 in Sertoli cells. Since xe-
noestrogens could potentially cause estrogen-like ac-
tion through GPR30 in a wide range of tissues, ex-
tensive studies on the biological function of GPR30
are needed to determine the action induced by xe-
noestrogens.
In summary, we showed that GPR30 was expressed
in rat Sertoli cells at both gene and protein level. The
exposure of Sertoli cells to MBP influenced the ex-
pression of GPR30. This might indicate that GPR30
may be a potential mediator of the action of MBP on
Sertoli cells. Future studies should demonstrate
whether MBP has the ability to trigger the nongenom-
ic effects.
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